242 related articles for article (PubMed ID: 8918455)
21. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
22. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
23. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
24. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
Freed EO; Martin MA
J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546
[TBL] [Abstract][Full Text] [Related]
25. The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions.
Katz E; Wolffe EJ; Moss B
J Virol; 1997 Apr; 71(4):3178-87. PubMed ID: 9060681
[TBL] [Abstract][Full Text] [Related]
26. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
Dorfman T; Mammano F; Haseltine WA; Göttlinger HG
J Virol; 1994 Mar; 68(3):1689-96. PubMed ID: 8107229
[TBL] [Abstract][Full Text] [Related]
27. Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation.
Margottin F; Benichou S; Durand H; Richard V; Liu LX; Gomas E; Benarous R
Virology; 1996 Sep; 223(2):381-6. PubMed ID: 8806575
[TBL] [Abstract][Full Text] [Related]
28. Interaction of human immunodeficiency virus gp120 with the voltage-gated potassium channel BEC1.
Herrmann M; Ruprecht K; Sauter M; Martinez J; van Heteren P; Glas M; Best B; Meyerhans A; Roemer K; Mueller-Lantzsch N
FEBS Lett; 2010 Aug; 584(16):3513-8. PubMed ID: 20638388
[TBL] [Abstract][Full Text] [Related]
29. Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions.
Lopez-Vergès S; Camus G; Blot G; Beauvoir R; Benarous R; Berlioz-Torrent C
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14947-52. PubMed ID: 17003132
[TBL] [Abstract][Full Text] [Related]
30. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.
Yu X; Yuan X; Matsuda Z; Lee TH; Essex M
J Virol; 1992 Aug; 66(8):4966-71. PubMed ID: 1629961
[TBL] [Abstract][Full Text] [Related]
31. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
Mammano F; Kondo E; Sodroski J; Bukovsky A; Göttlinger HG
J Virol; 1995 Jun; 69(6):3824-30. PubMed ID: 7745730
[TBL] [Abstract][Full Text] [Related]
32. Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release.
Noble B; Abada P; Nunez-Iglesias J; Cannon PM
J Virol; 2006 Mar; 80(6):2924-32. PubMed ID: 16501101
[TBL] [Abstract][Full Text] [Related]
33. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions.
Ono A; Huang M; Freed EO
J Virol; 1997 Jun; 71(6):4409-18. PubMed ID: 9151831
[TBL] [Abstract][Full Text] [Related]
34. Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation.
Tedbury PR; Novikova M; Ablan SD; Freed EO
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E182-90. PubMed ID: 26711999
[TBL] [Abstract][Full Text] [Related]
35. Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein.
Emerson V; Holtkotte D; Pfeiffer T; Wang IH; Schnölzer M; Kempf T; Bosch V
J Virol; 2010 Feb; 84(3):1355-65. PubMed ID: 19906925
[TBL] [Abstract][Full Text] [Related]
36. Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain.
Ye L; Bu Z; Vzorov A; Taylor D; Compans RW; Yang C
J Virol; 2004 Dec; 78(24):13409-19. PubMed ID: 15564451
[TBL] [Abstract][Full Text] [Related]
37. Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.
West JT; Weldon SK; Wyss S; Lin X; Yu Q; Thali M; Hunter E
J Virol; 2002 Apr; 76(7):3338-49. PubMed ID: 11884559
[TBL] [Abstract][Full Text] [Related]
38. The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter].
Wyss S; Berlioz-Torrent C; Boge M; Blot G; Höning S; Benarous R; Thali M
J Virol; 2001 Mar; 75(6):2982-92. PubMed ID: 11222723
[TBL] [Abstract][Full Text] [Related]
39. Efficient incorporation of HLA class II onto human immunodeficiency virus type 1 requires envelope glycoprotein packaging.
Poon DT; Coren LV; Ott DE
J Virol; 2000 Apr; 74(8):3918-23. PubMed ID: 10729169
[TBL] [Abstract][Full Text] [Related]
40. Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles.
Merten CA; Stitz J; Braun G; Poeschla EM; Cichutek K; Buchholz CJ
J Virol; 2005 Jan; 79(2):834-40. PubMed ID: 15613311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
